BriaCell Therapeutics Corp. (BCTX) — Dilution Risk Analysis
Current Snapshot
BriaCell Therapeutics Corp. (BCTX) has a DilutionWatch score of 67/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 67/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 8-K 2, EFFECT 1, S-1 1, XBRL 2.
| Form | Filed | Accession |
|---|---|---|
| 8-K | 2026-02-20 | 0001493152-26-007587 |
| 8-K | 2026-01-15 | 0001493152-26-002430 |
| EFFECT | 2026-01-13 | 9999999995-26-000157 |
| S-1 | 2025-12-23 | 0001493152-25-028916 |
| xbrl | 2025-07-31 | xbrl-6394-xbrl_warrant |
| xbrl | 2021-07-31 | xbrl-6394-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $24,999,999 | Source |
| Cash runway | 10 months | Source |
| Three-year share count growth | 2077.43% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 67/10) Source
- Cash Runway
- 10 months Source
- Shelf Registration Capacity
- $24,999,999 Source
- Share Count Growth (3-Year)
- 2077.43% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.